Judith Pirngruber

748 total citations
8 papers, 559 citations indexed

About

Judith Pirngruber is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Judith Pirngruber has authored 8 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Surgery. Recurrent topics in Judith Pirngruber's work include RNA modifications and cancer (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA Research and Splicing (3 papers). Judith Pirngruber is often cited by papers focused on RNA modifications and cancer (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA Research and Splicing (3 papers). Judith Pirngruber collaborates with scholars based in Germany, United States and France. Judith Pirngruber's co-authors include Steven A. Johnsen, Andrei Shchebet, Yael Aylon, Efrat Shema, Neri Minsky, Moshe Oren, Rob D. Chapman, Lisa Schreiber, Dirk Eick and Itay Tirosh and has published in prestigious journals such as Genes & Development, Cancer Research and Oncogene.

In The Last Decade

Judith Pirngruber

8 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judith Pirngruber Germany	6	499	88	50	42	28	8	559
Jayanthi Gudikote United States	11	454 0.9×	72 0.8×	48 1.0×	24 0.6×	32 1.1×	15	531
Pravina Fernandez United States	4	514 1.0×	79 0.9×	43 0.9×	30 0.7×	52 1.9×	11	572
Jay F. Sarthy United States	10	433 0.9×	44 0.5×	59 1.2×	36 0.9×	32 1.1×	24	531
Mathias Jenal Switzerland	9	518 1.0×	75 0.9×	77 1.5×	31 0.7×	73 2.6×	9	638
Craig MacKay United Kingdom	5	357 0.7×	111 1.3×	92 1.8×	51 1.2×	25 0.9×	6	423
Chris van Oevelen Spain	10	630 1.3×	74 0.8×	56 1.1×	64 1.5×	70 2.5×	10	716
Kun Cai China	6	274 0.5×	100 1.1×	82 1.6×	26 0.6×	64 2.3×	9	397
Leenus Martin United States	9	378 0.8×	86 1.0×	69 1.4×	33 0.8×	22 0.8×	11	476
Zehui Hong China	9	527 1.1×	149 1.7×	73 1.5×	66 1.6×	19 0.7×	11	568
Maria Poulsen Denmark	6	449 0.9×	192 2.2×	64 1.3×	37 0.9×	45 1.6×	8	528

Countries citing papers authored by Judith Pirngruber

Since Specialization

Citations

This map shows the geographic impact of Judith Pirngruber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Pirngruber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Pirngruber more than expected).

Fields of papers citing papers by Judith Pirngruber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Pirngruber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Pirngruber. The network helps show where Judith Pirngruber may publish in the future.

Co-authorship network of co-authors of Judith Pirngruber

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Pirngruber. A scholar is included among the top collaborators of Judith Pirngruber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Pirngruber. Judith Pirngruber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Pirngruber, Judith, Eva‐Maria Willing, Markus Falk, et al.. (2023). The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations. Current Oncology. 30(10). 8805–8814. 2 indexed citations

2.

Pirngruber, Judith & Steven A. Johnsen. (2010). Induced G1 cell-cycle arrest controls replication-dependent histone mRNA 3′ end processing through p21, NPAT and CDK9. Oncogene. 29(19). 2853–2863. 38 indexed citations

3.

Rüether, Klaus, Andreas Feigenspan, Judith Pirngruber, et al.. (2010). PKCα Is Essential for the Proper Activation and Termination of Rod Bipolar Cell Response. Investigative Ophthalmology & Visual Science. 51(11). 6051–6051. 36 indexed citations

4.

Rosenberger, Albert, Svantje Tauber, Christian Dullin, et al.. (2009). Antitumor Effects of a Combined 5-Aza-2′Deoxycytidine and Valproic Acid Treatment on Rhabdomyosarcoma and Medulloblastoma in Ptch Mutant Mice. Cancer Research. 69(3). 887–895. 85 indexed citations

5.

Pirngruber, Judith, Andrei Shchebet, Lisa Schreiber, et al.. (2009). CDK9 directs H2B monoubiquitination and controls replication‐dependent histone mRNA 3′‐end processing. EMBO Reports. 10(8). 894–900. 135 indexed citations

6.

Pirngruber, Judith, Andrei Shchebet, & Steven A. Johnsen. (2009). Insights into the function of the human P-TEFb component CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA processing. Cell Cycle. 8(22). 3636–3642. 38 indexed citations

7.

Pirngruber, Judith, Andrei Shchebet, Lisa Schreiber, et al.. (2009). CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA. 1 indexed citations

8.

Shema, Efrat, Itay Tirosh, Yael Aylon, et al.. (2008). The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression. Genes & Development. 22(19). 2664–2676. 224 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact